Risk Factors of Brain Metastasis During the Course of EGFR-TKIs Therapy for Patients With EGFR-mutated Advanced Lung Adenocarcinoma
Oncotarget - United States
doi 10.18632/oncotarget.11918
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 8, 2016
Authors
Publisher
Impact Journals, LLC